NCT04774198Completed
Perioperative Immune Function and Clinical Complications in Pancreaduodenectomy
Source: ClinicalTrials.gov · Last updated 12 Jun 2026
Brief summary (registry, in English)
Perioperative immunologic signatures can predict the risk of postoperative complications. The results will be puplished as two smanuscripts. The manuscript will focus on preoperative immunologisk data,the second manuscript will include both pre- and postoperative data.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 58 (actual)
- First submitted
- 31 Jan 2021
- Start date
- Feb 2021
- Primary completion date
- Dec 2023
- Lead sponsor
- Copenhagen University Hospital, Rigshospitalet
- Diseases
- Pancreatic cancer
- NCT number
- NCT04774198
What you commit to
- Study type: Observational
- Participants enrolled: 58
- From Feb 2021 to the primary completion date, Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients receiving immunomodulating treatment 1 month properatively and/or autoimmune diseases and patients non-cenacerous cystic lessions
- Inoperable patients, for instance, due to carcinosis, circulatory/ventilatory instability hindering procedure completion and/or concomitant surgery on major arterial blood vessels, spleen, or liver, are excluded post-inclusion and will not be part of the primary analysis
- ongoing treatment with glucocortocoid, anti-tnf-alpha etc.
Other illness
- patients diagnosed with rheumatological diseases, IBD or chronic infection (eg. HIV)
Lab values
- Bilirubin \>100 µmol/ltr
Other
- Patients scheduled for simultaneous procedures on major arterial blood vessels, and/or adjacent organs (spleen, liver)
Who the study is looking for
- Scheduled for PD on the suspicion of pancreatic cancer
- Patients able to follow standardised surgical procedure including TIVA anaesthesia with epidural
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rigshospitalet Coordinator of this site? Confirm its status | Copenhagen | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.